These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280 [TBL] [Abstract][Full Text] [Related]
4. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J Cochrane Database Syst Rev; 2011 Jun; (6):CD008143. PubMed ID: 21678374 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials. Rehman MB; Tudrej BV; Soustre J; Buisson M; Archambault P; Pouchain D; Vaillant-Roussel H; Gueyffier F; Faillie JL; Perault-Pochat MC; Cornu C; Boussageon R Diabetes Metab; 2017 Feb; 43(1):48-58. PubMed ID: 27745828 [TBL] [Abstract][Full Text] [Related]
6. Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus. Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Gerlach FM Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013228. PubMed ID: 30556900 [TBL] [Abstract][Full Text] [Related]
7. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus. Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975 [TBL] [Abstract][Full Text] [Related]
8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
9. Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials. Li J; Tong Y; Zhang Y; Tang L; Lv Q; Zhang F; Hu R; Tong N Clin Ther; 2016 Feb; 38(2):372-386.e6. PubMed ID: 26774276 [TBL] [Abstract][Full Text] [Related]
10. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. Wu JH; Foote C; Blomster J; Toyama T; Perkovic V; Sundström J; Neal B Lancet Diabetes Endocrinol; 2016 May; 4(5):411-9. PubMed ID: 27009625 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis. Pittas AG; Westcott GP; Balk EM Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170 [TBL] [Abstract][Full Text] [Related]
12. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials. Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461 [TBL] [Abstract][Full Text] [Related]
13. Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses. Hemmingsen B; Christensen LL; Wetterslev J; Vaag A; Gluud C; Lund SS; Almdal T BMJ; 2012 Apr; 344():e1771. PubMed ID: 22517929 [TBL] [Abstract][Full Text] [Related]
14. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. Boussageon R; Bejan-Angoulvant T; Saadatian-Elahi M; Lafont S; Bergeonneau C; Kassaï B; Erpeldinger S; Wright JM; Gueyffier F; Cornu C BMJ; 2011 Jul; 343():d4169. PubMed ID: 21791495 [TBL] [Abstract][Full Text] [Related]
15. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Gooßen K; Gräber S Diabetes Obes Metab; 2012 Dec; 14(12):1061-72. PubMed ID: 22519906 [TBL] [Abstract][Full Text] [Related]
17. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Butalia S; Gutierrez L; Lodha A; Aitken E; Zakariasen A; Donovan L Diabet Med; 2017 Jan; 34(1):27-36. PubMed ID: 27150509 [TBL] [Abstract][Full Text] [Related]
18. Comparison of cardiovascular and metabolic outcomes in people with type 2 diabetes on insulin versus non-insulin glucose-lowering therapies (GLTs): A systematic review and meta-analysis of clinical trials. Anyanwagu U; Mamza J; Donnelly R; Idris I Diabetes Res Clin Pract; 2016 Nov; 121():69-85. PubMed ID: 27662041 [TBL] [Abstract][Full Text] [Related]